University of Chicago MedicineUniversity of Chicagoaxicabtagene ciloleucelr/r DLBCLCD19-targeted chimeric antigen receptor (CAR) T-cell therapy
…nder Institutional Review Board (IRB)-approved protocols at the University of Chicago Medicine (IRB #18-0025), with informed consent obtained from all patient…